Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1989 1
1990 2
1992 1
1993 1
1994 1
1996 2
1998 6
1999 2
2000 1
2001 2
2002 1
2003 1
2005 2
2006 1
2009 3
2011 1
2012 1
2013 2
2018 1
2019 1
2020 1
2021 2
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for enteral ciprofloxacin
Your search for citeral-ciprofloxacin retrieved no results
Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.
Healy DP, Brodbeck MC, Clendening CE. Healy DP, et al. Antimicrob Agents Chemother. 1996 Jan;40(1):6-10. doi: 10.1128/AAC.40.1.6. Antimicrob Agents Chemother. 1996. PMID: 8787869 Free PMC article. Clinical Trial.
Twenty-six hospitalized patients participated in a randomized crossover study to evaluate the effect of enteral feedings on ciprofloxacin absorption when given orally or via gastrostomy or jejunostomy tubes. ...The decreased absorption may be clinically important, e …
Twenty-six hospitalized patients participated in a randomized crossover study to evaluate the effect of enteral feedings on ciprof …
Administration of ciprofloxacin through a nasogastric tube in pediatric oncology and stem cell transplantation patients.
Bauters T, Buyle F, Schelstraete P, Dhooge C. Bauters T, et al. J Oncol Pharm Pract. 2023 Mar;29(2):413-415. doi: 10.1177/10781552221147891. Epub 2022 Dec 26. J Oncol Pharm Pract. 2023. PMID: 36572994
However, its co-administration with polyvalent cations (as present in enteral feeding) makes the absorption of ciprofloxacin more difficult and may alter the pharmacokinetic parameters. Literature data are conflicting on how long the enteral feeding should be …
However, its co-administration with polyvalent cations (as present in enteral feeding) makes the absorption of ciprofloxacin m …
Clinical Equivalency of Ciprofloxacin 750 mg Enterally and 400 mg Intravenously for Patients Receiving Enteral Feeding: Systematic Review.
Chui D, Cheng L, Tejani AM. Chui D, et al. Can J Hosp Pharm. 2009 Mar;62(2):127-34. doi: 10.4212/cjhp.v62i2.441. Can J Hosp Pharm. 2009. PMID: 22478878 Free PMC article.
BACKGROUND: Concomitant enteral administration of ciprofloxacin with products containing magnesium, aluminum, and calcium (e.g., as enteral feeds) decreases the oral bioavailability of this antibiotic. ...OBJECTIVE: To evaluate whether ciprofloxacin 75 …
BACKGROUND: Concomitant enteral administration of ciprofloxacin with products containing magnesium, aluminum, and calcium (e.g …
Enteral antipseudomonal fluoroquinolones for ventilator-associated tracheobronchitis in children with pre-existing tracheostomy.
Smith CJ, Sierra CM, Robbins J, Cobbina E. Smith CJ, et al. Pediatr Pulmonol. 2022 Apr;57(4):1064-1071. doi: 10.1002/ppul.25816. Epub 2022 Jan 17. Pediatr Pulmonol. 2022. PMID: 34989477
INTRODUCTION: Pseudomonas aeruginosa is the most commonly isolated organism in tracheostomy-dependent children with ventilator-associated tracheobronchitis (VAT). Enteral treatment with an antipseudomonal fluoroquinolone such as ciprofloxacin or levofloxacin is some …
INTRODUCTION: Pseudomonas aeruginosa is the most commonly isolated organism in tracheostomy-dependent children with ventilator-associated tr …
Burden of enteral supplement interactions with common antimicrobial agents: a single-centre observational analysis.
Hughes S, Heard K, Mughal N, Moore LSP. Hughes S, et al. Eur J Hosp Pharm. 2022 Sep;29(5):280-283. doi: 10.1136/ejhpharm-2020-002445. Epub 2021 Jan 7. Eur J Hosp Pharm. 2022. PMID: 33414257 Free PMC article.
INTRODUCTION: Oral antimicrobials, including ciprofloxacin, levofloxacin and doxycycline, are susceptible to binding with enteral therapies such as calcium and iron therapies. ...CONCLUSION: The concomitant administration of enteral calcium and iron with oral …
INTRODUCTION: Oral antimicrobials, including ciprofloxacin, levofloxacin and doxycycline, are susceptible to binding with enteral …
Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections.
de Marie S, VandenBergh MF, Buijk SL, Bruining HA, van Vliet A, Kluytmans JA, Mouton JW. de Marie S, et al. Intensive Care Med. 1998 Apr;24(4):343-6. doi: 10.1007/s001340050577. Intensive Care Med. 1998. PMID: 9609412 Clinical Trial.
OBJECTIVE: To determine the bioavailability of enteral ciprofloxacin in tube-fed intensive care patients with severe GNIAI. ...CONCLUSIONS: In tube-fed intensive care patients with severe GNIAI, the bioavailability of enteral ciprofloxacin is adequate. …
OBJECTIVE: To determine the bioavailability of enteral ciprofloxacin in tube-fed intensive care patients with severe GNIAI. .. …
Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.
Mueller BA, Brierton DG, Abel SR, Bowman L. Mueller BA, et al. Antimicrob Agents Chemother. 1994 Sep;38(9):2101-5. doi: 10.1128/AAC.38.9.2101. Antimicrob Agents Chemother. 1994. PMID: 7811026 Free PMC article. Clinical Trial.
The relative oral bioavailabilities of ciprofloxacin and ofloxacin when they were coadministered with water or an enteral feeding product (Ensure) were assessed in 13 healthy volunteers. ...Coadministration of Ensure significantly diminished ciprofloxacin and …
The relative oral bioavailabilities of ciprofloxacin and ofloxacin when they were coadministered with water or an enteral feed …
Fluoroquinolones: interaction profile during enteral absorption.
Deppermann KM, Lode H. Deppermann KM, et al. Drugs. 1993;45 Suppl 3:65-72. doi: 10.2165/00003495-199300453-00013. Drugs. 1993. PMID: 7689454 Review.
This paper is a review of drug interactions with different quinolone derivatives at the absorption phase; the review deals mainly with the prototype quinolones, ciprofloxacin and ofloxacin, and also with some of the newer agents. ...
This paper is a review of drug interactions with different quinolone derivatives at the absorption phase; the review deals mainly with the p …
Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding.
Yuk JH, Nightingale CH, Sweeney KR, Quintiliani R, Lettieri JT, Frost RW. Yuk JH, et al. Antimicrob Agents Chemother. 1989 Jul;33(7):1118-20. doi: 10.1128/AAC.33.7.1118. Antimicrob Agents Chemother. 1989. PMID: 2506806 Free PMC article.
Each subject received, on separate occasions, an intact 750-mg ciprofloxacin tablet, a crushed tablet as a suspension through an NG tube, and a crushed tablet as a suspension through an NG tube while receiving enteral feeding. No statistically significant difference …
Each subject received, on separate occasions, an intact 750-mg ciprofloxacin tablet, a crushed tablet as a suspension through an NG t …
41 results